Publication Cover
Stress
The International Journal on the Biology of Stress
Volume 13, 2010 - Issue 6
246
Views
11
CrossRef citations to date
0
Altmetric
Original Research Reports

Nociceptin/orphanin FQ and the regulation of neuronal excitability in the rat bed nucleus of the stria terminalis: Interaction with glucocorticoids

, &
Pages 516-527 | Received 18 Jan 2010, Accepted 12 Apr 2010, Published online: 28 Jul 2010

References

  • Choi DC, Furay AR, Evanson NK, Ostrander MM, Ulrich-Lai YM, Herman JP. 2007. Bed nucleus of the stria terminalis subregions differentially regulate hypothalamo-pituitary-adrenal axis activity: Implications for the integration of limbic inputs. J Neurosci. 27:2025–2034.
  • Cintra A, Fuxe K, Härfstrand A, Agnati LF, Wikström AC, Okret S, Vale W, Gustafsson JA. 1987. Presence of glucocorticoid receptor immunoreactivity in corticotrophin releasing factor and in growth hormone releasing factor immunoreactive neurones of the rat di- and telencephalon. Neurosci Lett. 77:25–30.
  • Ciccocioppo R, Fedeli A, Economidou D, Policani F, Weiss F, Massi M. 2003. The bed nucleus is a neuroanatomical substrate for the anorectic effect of corticotropin-releasing factor and for its reversal by nociceptin/orphanin FQ. J Neurosci. 23:9445–9451.
  • Crestani CC, Alves FHF, Tavares RF, Correa FMA. 2009. Roles of the bed nucleus of the stria terminalis in the cardiovascular response to acute restraint stress in rats. Stress. 12:268–278.
  • Cullinan WE, Herman JP, Watson SJ. 1993. Ventral subicular interaction with the hypothalamic paraventricular nucleus: Evidence for a relay in the bed nucleus of the stria terminalis. J Comp Neurol. 332:1–20.
  • Dong HW, Petrovich GD, Swanson L. 2001. Topography of projections from amygdala to bed nuclei of the stria terminalis. Brain Res Rev. 38:192–246.
  • Duvarci S, Pare D. 2007. Glucocorticoids enhance the excitability of principal basolateral amygdala neurones. J Neurosci. 27:4482–4491.
  • Egli RE, Winder DG. 2003. Dorsal and ventral distribution of excitable and synaptic properties of neurons of the bed nucleus of the stria terminalis. J Neurophysiol. 90:405–414.
  • Emmerson PJ, Miller RJ. 1999. Pre- and postsynaptic actions of opioid and orphan opioid agonists in the rat arculate nucleus and ventromedial hypothalamus in vitro. J Physiol. 517:431–445.
  • Feldman S, Conforti N, Saphier D. 1990. The preoptic area and bed nucleus of the stria terminalis are involved in the effects of the amygdala on adrenocortical secretion. Neuroscience. 37:775–779.
  • Forray MI, Gysling K. 2004. Role of noradrenergic projections to the bed nucleus of the stria terminalis in the regulation of the hypothalamo-pituitary-adrenal axis. Brain Res Rev. 47:145–160.
  • Gray TS, Piechowski RA, Yracheta JM, Rittenhouse PA, Bethea CL, Van de Kar LD. 1993. Ibotenic acid lesions in the bed nucleus of stria terminalis attenuates conditioned stress-induced increases in prolactin, ACTH and corticosterone. Neuroendocrinology. 57:517–524.
  • Hammack SE, Mania I, Rainnie DG. 2007. Differential expression of intrinsic membrane currents in defined cell types of the anterolateral bed nucleus of the stria terminalis. J Neurophysiol. 98:638–656.
  • Green MK, Barbieri EV, Brown BD, Chen KW, Devine DP. 2007. Roles of the bed nucleus of stria terminalis and of the amygdala in N/OFQ-mediated anxiety and HPA axis activation. Neuropeptides. 41:399–410.
  • Ju G, Swanson LW. 1989. Studies on the cellular architecture of the bed nuclei of the stria terminalis in the rat: I. Cytoarchitecture. J Comp Neurol. 280:587–602.
  • Ju G, Swanson LW, Simerly RB. 1989. Studies on the cellular architecture of the bed nuclei of the stria terminalis in the rat: II. Chemoarchitecture. J Comp Neurol. 280:603–621.
  • Karst H, Nair S, Velzing E, Rumpff-van Essen L, Slagter E, Shinnick-Gallagher P, Joëls M. 2002. Glucocorticoids alter calcium conductances and calcium channel subunit expression in basolateral amygdala neurons. Eur J Neurosci. 16:1083–1089.
  • Lechner SM, Valentino RJ. 1999. Glucocorticoid receptor-immunoreactivity in corticotrophin-releasing factor afferents to the locus coeruleus. Brain Res. 816:17–28.
  • Leggett JD, Harbuz MS, Jessop DS, Fulford AJ. 2006. The nociceptin receptor antagonist UFP-101 blocks the stimulatory effects of nociceptin on the HPA axis. Neurosci. 141:2051–2057.
  • Leggett JD, Jessop DS, Fulford AJ. 2007. The nociceptin/orphanin FQ antagonist UFP-101 differentially modulates the glucocorticoid response to restraint stress in rats during the peak and nadir phases of the HPA axis circadian rhythm. Neuroscience. 147:757–764.
  • Leggett JD, Dawe KL, Jessop DS, Fulford AJ. 2009. Endogenous Nociceptin/Orphanin FQ system involvement in HPA axis responses: Relevance to models of inflammation. J Neuroendocrinology. 21:888–897.
  • Meis S. 2003. Nociceptin/orphanin FQ: Actions within the brain. Neuroscientist. 9:158–168.
  • Mulders WH, Meek J, Hafmans TG, Cools AR. 1997. Plasticity in the stress-regulating circuit; decreased input from the bed nucleus of the stria terminalis to the hypothalamic paraventricular nucleus in Wistar rats following adrenalectomy. Eur J Neurosci. 9:2462–2471.
  • Neal CR, Akil H, Watson SJ. Expression of orphanin FQ and the opioid receptor-like (ORL1) receptor in the developing human and rat brain. J Chem Neuroanat. 1999a; 22:219–249.
  • Neal CR, Mansour A, Reinscheid R, Nothacker H-P, Civelli O, Watson SJ. Localisation of orphanin FQ (nociceptin) peptide and messenger RNA in the central nervous system of the rat. J Comp Neurol. 1999b; 406:503–547.
  • Pacak K, McCarty R, Palkovits M, Kopin IJ, Goldstein DS. 1995. Effects of immobilisation on in vivo release of norepinephrine in the bed nucleus of the stria terminalis in conscious rats. Brain Res. 688:242–246.
  • Paxinos G, Watson C. 1997. The rat brain in stereotaxic coordinates. San Diego, USA: Academic Press Inc.
  • Rodi D, Zucchini S, Simonato M, Cifani C, Massi M, Polidori C. 2008. Functional antagonism between nociceptin/orphanin FQ (N/OFQ) and corticotrophin-releasing factor (CRF) in the rat brain: Evidence for involvement of the bed nucleus of the stria terminalis. Psychopharmacology. 196:523–531.
  • Sakanaka M, Shibasaki T, Lederis K. 1986. Distribution and efferent projections of corticotrophin-releasing factor-like immunoreactivity in the rat amygdaloid complex. Brain Res. 382:213–238.
  • Shimada S, Inagaki S, Kubota Y, Ogawa N, Shibasaki T, Takagi H. 1989. Coexistence of peptides (corticotropin releasing factor/neurotensin and substance P/somatostatin) in the bed nucleus of the stria terminalis and central amygdaloid nucleus of the rat. Neuroscience. 30:377–383.
  • Shirasaka T, Miyahara S, Takasaki M, Kannan H. 2001. Nociceptin/orphanin FQ and [Phe(1)psi(CH2-NH)Gly2]nociceptin(1-13)NH2 modulates the activity of hypothalamic paraventricular nucleus neurones in vitro. Brain Res. 890:147–153.
  • van Eekelen JA, Bohn MC, de Kloet ER. 1991. Postnatal ontogeny of mineralocorticoid and glucocorticoid receptor gene expression in regions of the rat tel- and diencephalon. Brain Res Dev Brain Res. 61:33–43.
  • Walker DL, Davis M. 1997. Double dissociation between the involvement of the bed nucleus of the stria terminalis and the central nucleus of the amygdala in startle increases produced by conditioned versus unconditioned fear. J Neurosci. 17:9375–9383.
  • Walter A, Mai JK, Lanta L, Gorcs T. 1991. Differential distribution of immunohistochemical markers in the bed nucleus of the stria terminalis in the human brain. J Chem Neuroanat. 4:281–298.
  • Weitlauf C, Egli RE, Grueter BA, Winder DG. 2004. High-frequency stimulation induces ethanol-sensitive long-term potentiation at glutamatergic synapses in the dorsolateral bed nucleus of the stria terminalis. J Neurosci. 24:5741–5747.
  • Woulfe JM, Flumerfelt BA, Hrycyshyn AW. 1990. Efferent connections of the A1 noradrenergic cell group: A DBH immunohistochemical and PHA-L anterograde tracing study. Exp Neurol. 109:308–322.
  • Yu T-P, Xie C-W. 1998. Orphanin FQ/nociceptin inhibits synaptic transmission and long-term potentiation in rat dentate gyrus through postsynaptic mechanisms. J Neurophysiol. 80:1277–1284.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.